Almorexant in Primary Insomnia

Clinical trial NCT00640848 · COMPLETED

Trial details

NCT number: NCT00640848
Sponsor: Midnight Pharma, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Insomnia Primary Insomnia

Start date: 2006-05-01
Primary completion: 2007-08-01
Enrollment: 161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.